Financing Methods

MSA
1. Characteristics
2. Patient Empowerment & Cost Control
  1. China = no LR CC
  2. US Review
  3. Singapore
3. Efficiency
  1. R.R.P
  2. Singapor & US
4. Financial Protection
  1. S: <5% 2009 THE
5. General eval
  1. Dixon 2002
6. NO COUNTRY
Use Charges
1. General
  1. 3 Types
  2. EU
2. Protection Mechanisms
3. Economic Rationale
  1. Moral Hazard
    1. Blunt
    2. Nyman
  2. Cost Control
    1. Rand: Yes
    2. Prescriptions: No
    3. Capacity
    4. US: Admin
4. Eff: Wagstaff (2005):China
5. Equity Issue
  1. RAND
  2. Well vs Sick
6. Efficiency
  1. Nyman:No
    1. CEA
Tax
1. Characteristics
2. Efficiency
3. Equity
4. Political Feasibility
5. Types of Taxes Vs
  1. General vs Earmarked
    1. hypothecated_Aus
  2. Direct v Indirect
    1. Cap
  3. Local v National
    1. Italy & Spain
      1. Italy
    2. R-A
6. Tax v PHI
8. Beveridge
SHI
1. SHI v Tax
2. Characteristics
  1. not levied on savings or K gains
3. Issues
4. Bismarck
General
1. Intro
2. Functions
  1. Pooling
    1. Eff
  2. Collection
  3. Purchasing
    1. R-A
3. Efficiency
  1. Why
  2. WHO
  3. T.P.A
4. Eval Aspects
  1. Coverage
  2. Financial Protection
  3. Sustainability
  4. Poltical Feasibility
  5. Equity
Health Insurance
1. Extent of Risk Protection
  1. Intro
  2. PHI
    1. Role
      1. VHI: Role Expanded
        Sub
        Germany
        Comp_1&2
        2: France
        Sup
        Ireland
    2. Flaws
    3. Conditions
      1. Long term care
        Dilnot
  3. SHI
    2. PHI v SHI
2. Solutions
3. Other Factors
  1. Efficiency
  2. Equity
  3. Prediction

Next up

Financing Methods

Description

Resource summary

Similar

	Created by nrnaylor about 11 years ago